School of Medicine
Showing 2,481-2,490 of 13,034 Results
-
Mary de Boer
Postdoctoral Scholar, Infectious Diseases
BioI am a maternal and child nutrition researcher with expertise in nutritional epidemiology, implementation science, and environmental health. My work focuses on understanding heterogeneity in health outcomes among pregnant women in low- and middle-income countries — specifically, why evidence-based interventions fail to reach or benefit the most vulnerable subgroups. I use mixed methods combining traditional nutritional epidemiology with spatial analysis, multilevel and structural equation modeling, latent class analysis, and qualitative approaches to understand both biological and structural drivers of that heterogeneity. I come to academic research after 14 years as a field-based public health practitioner in Sub-Saharan Africa and Central Asia within the USAID Foreign Service.
-
Walter De Brouwer
Adjunct Professor, Medicine - Primary Care and Population Health
BioWalter A. De Brouwer, Ph.D., is an Adjunct Professor at the Stanford School of Medicine. As a core faculty member at CERC DICE, he is the course director for “Innovation in Healthcare: from idea to incorporation,” which includes a bi-weekly presentation. He also serves on the advisory committee focused on the strategic direction for the program and is part of the leadership team developing the program curriculum and practicum. He is the founder of doc.ai, a Palo-Alto-based Federated Edge Learning company for the payers/pharma industry which merged in January 2020 with Sharecare Inc.
Professional Education
Bachelor’s degree in Philology (University of Ghent, Belgium)
Master’s degree in Formal Linguistics (University of Ghent, Belgium)
Post-graduate: Epistemology (University of Ghent, Belgium)
Ph.D. Computational Semiotics (Catholic University of Tilburg, the Netherlands). -
Korina De Bruyne
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsThe EMPOWER study (PI: Dr Beth Darnall) is looking at how to best support patients with chronic pain on long-term opioid therapy through a slow taper (maximal duration of 1 year). Patients are randomized to taper only versus taper plus community-based pain self-management group sessions versus taper plus psychologist-led cognitive behavioral therapy for pain group sessions. Along the way alternative measures to control pain are also explored. Enrollment is open until 10/2021.
-
Sallie De Golia
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is Director of Coaching and Senior Faculty Educational Consultant in Stanford's Department of Psychiatry and Behavioral Sciences. She is a Peer Teaching Coach and Fellow in the Stanford Teaching and Mentoring Academy, has taught regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.
-
Michelle de Haaff
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Director of Digital Health
Co-Instructor Biodesign for Digital Health (Fall) and Biodesign for Societal Health (Winter)
Stanford Byers Center for Biodesign -
Vinicio de Jesus Perez MD
Associate Dean of Stanford MD Admissions and Professor of Medicine (PACCM)
Current Research and Scholarly InterestsMy research focuses on the molecular and cellular mechanisms that drive pulmonary vascular disease, particularly pulmonary arterial hypertension (PAH). I study how endothelial dysfunction, impaired vascular repair, pericyte abnormalities, inflammation, and metabolic dysregulation contribute to pulmonary vascular remodeling and right ventricular failure. Through the integration of human tissue studies, advanced Omics technologies, and translational animal models, my work aims to identify novel th
